The combination of mycophenolate mofetil with corticosteroids induces remission of henoch-schnlein purpura nephritis

American Journal of Nephrology

Volumn 36, Issue 3, 2012, Pages 271-277

  Ren, Pingping ^a   Han, Fei ^a   Chen, Liangliang ^a   Xu, Yu ^b   Wang, Ying ^b   Chen, Jianghua ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Adult; Corticosteroids; Henoch Sch nlein purpura nephritis; Mycophenolate mofetil; Side effects

Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ADULT; ANAPHYLACTOID PURPURA; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN URINE LEVEL; REMISSION; RETROSPECTIVE STUDY;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; BIOPSY; CHINA; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; NEPHRITIS; PROTEINURIA; PURPURA, SCHOENLEIN-HENOCH; RECURRENCE; REMISSION INDUCTION; RETROSPECTIVE STUDIES;

EID: 84865838304     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000341914     Document Type: Article

References (24)

1. Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, Kawasaki T, Lindsley C, Petty RE, Prieur AM, Ravelli A, Woo P: EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 2006; 65: 936-941.
2. Kellerman PS: Henoch-Schönlein purpura in adults. Am J Kidney Dis 2006; 48: 1009-1016.
3. Shenoy M, Bradbury MG, Lewis MA, Webb NJ: Outcome of Henoch- Schönlein purpura nephritis treated with long-term immunosuppression. Pediatr Nephrol 2007; 22: 1717-1722.
4. Pillebout E, Thervet E, Hill G, Alberti C, Vanhille P, Nochy D: Henoch-Schönlein Purpura in adults: outcome and prognostic factors. J Am Soc Nephrol 2002; 13: 1271-1278.
5. Coppo R, Andrulli S, Amore A, Gianoglio B, Conti G, Peruzzi L, Locatelli F, Cagnoli L: Predictors of outcome in Henoch-Schönlein nephritis in children and adults. Am J Kidney Dis 2006; 47: 993-1003.
6. Coppo R, Mazzucco G, Cagnoli L, Lupo A, Schena FP: Long-term prognosis of Henoch-Schönlein nephritis in adults and children. Italian Group of Renal Immunopathology Collaborative Study on Henoch-Schönlein purpura. Nephrol Dial Transplant 1997; 12: 2277-2283.
7. Ronkainen J, Koskimies O, Ala-Houhala M, Antikainen M, Merenmies J, Rajantie J, Ormala T, Turtinen J, Nuutinen M: Early prednisone therapy in Henoch-Schönlein purpura: a randomized, double-blind, placebocontrolled trial. J Pediatr 2006; 149: 241-247.
8. Saag KG, Koehnke R, Caldwell JR, Brasington R, Burmeister LF, Zimmerman B, Kohler JA, Furst DE: Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events. Am J Med 1994; 96: 115-123.
9. Du Y, Hou L, Zhao C, Han M, Wu Y: Treatment of children with Henoch-Schönlein purpura nephritis with mycophenolate mofetil. Pediatr Nephrol 2012; 27: 765-771.
10. Appel GB, Contreras G, Dooley MA, Ginzler EM, Isenberg D, Jayne D, Li LS, Mysler E, Sanchez-Guerrero J, Solomons N, Wofsy D: Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis. J Am Soc Nephrol 2009; 20: 1103-1112.
11. Han F, Liu G, Zhang X, Li X, He Q, He X, Li Q, Wang S, Wang H, Chen J: Effects of mycophenolate mofetil combined with corticosteroids for induction therapy of microscopic polyangiitis. Am J Nephrol 2011; 33: 185-192.
12. Tang SC, Tang AW, Wong SS, Leung JC, Ho YW, Lai KN: Long-term study of mycophenolate mofetil treatment in IgA nephropathy. Kidney Int 2010; 77: 543-549.
13. Martin S, Cramer CH, Heikenen J, Gitomer JJ: Gastrointestinal symptoms of Henoch-Schönlein purpura treated with mycophenolate mofetil. J Pediatr Gastroenterol Nutr 2006; 43: 245-247.
14. Nikibakhsh AA, Mahmoodzadeh H, Karamyyar M, Hejazi S, Noroozi M, Macooie AA, Gholizadeh A, Gholizadeh L: Treatment of complicated Henoch-Schönlein purpura with mycophenolate mofetil: a retrospective case series report. Int J Rheumatol 2010; 2010: 254316.
15. Muzaffar M, Taj A, Sethi N, Kaw D: Rapidly progressing glomerulonephritis secondary to Henoch-Schönlein purpura treated with mycophenolate mofetil: a case report with atypical etiology andpresentation. Am J Ther 2010; 17:e163-e166.
16. Dede F, Onec B, Ayli D, Gonul II, Onec K: Mycophenolate mofetil treatment of crescentic Henoch-Schönlein nephritis with IgA depositions. Scand J Urol Nephrol 2008; 42: 178-180.
17. Mills JA, Michel BA, Bloch DA, Calabrese LH, Hunder GG, Arend WP, Edworthy SM, Fauci AS, Leavitt RY, Lie JT, et al: The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arthritis Rheum 1990; 33: 1114-1121.
18. Counahan R, Winterborn MH, White RH, Heaton JM, Meadow SR, Bluett NH, Swetschin H, Cameron JS, Chantler C: Prognosis of Henoch-Schönlein nephritis in children. Br Med J 1977; 2: 11-14.
19. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470.
20. Tanaka H, Suzuki K, Nakahata T, Ito E, Waga S: Early treatment with oral immunosuppressants in severe proteinuric purpura nephritis. Pediatr Nephrol 2003; 18: 347-350.
21. Chartapisak W, Opastiraku S, Willis NS, Craig JC, Hodson EM: Prevention and treatment of renal disease in Henoch-Schönlein purpura: a systematic review. Arch Dis Child 2009; 94: 132-137.
22. Pillebout E, Alberti C, Guillevin L, Ouslimani A, Thervet E: Addition of cyclophosphamide to steroids provides no benefit compared with steroids alone in treating adult patients with severe Henoch-Schönlein Purpura. Kidney Int 2010; 78: 495-502.
23. Chan TM, Li FK, Tang CS, Wong RW, Fang GX, Ji YL, Lau CS, Wong AK, Tong MK, Chan KW, Lai KN: Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group. N Engl J Med 2000; 343: 1156-1162.
24. Ginzler EM, Dooley MA, Aranow C, Kim MY, Buyon J, Merrill JT, Petri M, Gilkeson GS, Wallace DJ, Weisman MH, Appel GB: Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med 2005; 353: 2219-2228.